-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 F4Xq95xm0pZoLtVd5nosqEg4k2MVHreTZaeYmN5Qr5tFXq/7OwR+E7OuZo3VFSFw
 PxbLzaYDngus83+us7dOfw==

<SEC-DOCUMENT>0001016169-07-000030.txt : 20070514
<SEC-HEADER>0001016169-07-000030.hdr.sgml : 20070514
<ACCEPTANCE-DATETIME>20070514152441
ACCESSION NUMBER:		0001016169-07-000030
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20070510
FILED AS OF DATE:		20070514
DATE AS OF CHANGE:		20070514

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ANTARES PHARMA INC
		CENTRAL INDEX KEY:			0001016169
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				411350192
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		250 PHILLIPS BLVD
		STREET 2:		SUITE 290
		CITY:			EWING
		STATE:			NJ
		ZIP:			08618
		BUSINESS PHONE:		609-359-3020

	MAIL ADDRESS:	
		STREET 1:		250 PHILLIPS BLVD
		STREET 2:		SUITE 290
		CITY:			EWING
		STATE:			NJ
		ZIP:			08618

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANTARES PHARMA  INC
		DATE OF NAME CHANGE:	20020520

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANTARES PHARMA INC /MN/
		DATE OF NAME CHANGE:	20010604

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MEDI JECT CORP /MN/
		DATE OF NAME CHANGE:	19960605

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			JACOB LEONARD S
		CENTRAL INDEX KEY:			0001049713
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32302
		FILM NUMBER:		07846076

	BUSINESS ADDRESS:	
		STREET 1:		C/O INKINE PHARMACEUTICAL COMPANY INC
		STREET 2:		425 PARK AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		2123198300

	MAIL ADDRESS:	
		STREET 1:		C/O INKINE PHARMACEUTICAL COMPANY INC
		STREET 2:		425 PARK AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ljacob051407_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2007-05-10</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001016169</issuerCik>
        <issuerName>ANTARES PHARMA INC</issuerName>
        <issuerTradingSymbol>AIS</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001049713</rptOwnerCik>
            <rptOwnerName>JACOB LEONARD S</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ANTARES PHARMA, INC</rptOwnerStreet1>
            <rptOwnerStreet2>250 PHILLIPS BLVD, SUITE 290</rptOwnerStreet2>
            <rptOwnerCity>EWING</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>08618</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.65</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2007-05-10</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>41762</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <footnoteId id="F3"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2017-05-09</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>41762</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>41762</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">11,762 options were taken in lieu of a portion of the Director's annual cash compensation.</footnote>
        <footnote id="F2">The option vests in four equal quarterly installments.</footnote>
        <footnote id="F3">Not applicable.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/Leonard S. Jacob, M.D., Ph.D.</signatureName>
        <signatureDate>2007-05-14</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----